Exela Pharma Sciences LLC recalls

12 recalls on record

Recalls filed with 1 agency: FDA (12).

First recall on record: May 30, 2018. Most recent: September 17, 2025.

Risk classification: Class I: 7 · Class II: 4 · Class III: 1

Recalert records 12 recalls for Exela Pharma Sciences LLC from FDA. The earliest is dated May 30, 2018 and the latest September 17, 2025. 0 recalls are dated within the last 12 months. The most frequent categories are drug. The latest recall is 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton) (D-0620-2025).

Most recent recalls

DateAgencyProduct
September 17, 2025FDA4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Onl…D-0620-2025
April 2, 2025FDA8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose V…D-0303-2025
November 29, 2023FDAMidazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vi…D-0117-2024
November 29, 2023FDAELCYS (cysteine hydrochloride injection), USP, 500 mg/10mL (50 mg/mL), 10x10 mL Single Do…D-0118-2024
November 29, 2023FDA8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL Single Dose V…D-0116-2024
December 21, 2022FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, p…D-0080-2023
December 21, 2022FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, p…D-0079-2023
November 2, 2022FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, p…D-0023-2023
November 2, 2022FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, p…D-0022-2023
January 19, 2022FDA8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, Rx Only, Man…D-0369-2022
September 23, 2020FDAPotassium Acetate Injection, USP 40 mEq/20 mL (2 mEq/mL) Single Dose Vials, Rx only, Man…D-1585-2020
May 30, 2018FDADiclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mg, 60-count bottle, …D-0826-2018

Questions about this company

Does Exela Pharma Sciences LLC have recalls in 2026?
Recalert records 0 recalls for Exela Pharma Sciences LLC dated in 2026.

Do you carry products from Exela Pharma Sciences LLC? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies